Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
09/1998
09/02/1998EP0861898A1 Rat Cathepsin K polynucleotide & polypeptide sequence
09/02/1998EP0861895A2 aroE shikimate 5 dehydrogenase from Staphylococcus Aureus
09/02/1998EP0861890A1 LicC polypeptides from Streptococcus pneumoniae
09/02/1998EP0861889A1 LicD2 polypeptides from Streptococcus pneumoniae
09/02/1998EP0861850A1 Tumor necrosis related receptor, TR4
09/02/1998EP0861329A1 Dodecahedral adenoviral protein complex, composition containing same and uses thereof
09/02/1998EP0861320A1 Sequestrin
09/02/1998EP0861267A1 Inducing resistance to tumor growth with soluble igf-1 receptor
09/02/1998EP0861261A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
09/02/1998EP0861228A1 Lipopolyamines as transfection agents and pharmaceutical uses thereof
09/02/1998EP0861092A1 Therapy for cellular accumulation in chronic inflammatory diseases
09/02/1998EP0674716B1 Retroviral vectors for the treatment of tumors, and cell lines containing them
09/02/1998CN1192246A Cell line producing analgesic compounds for treating pain
09/02/1998CN1192158A Method of treatment for asthma
09/02/1998CN1191898A Self-enhancing, pharmacologically controllable expression systems
09/01/1998US5801234 Polynucleotide encoding saliva binding protein
09/01/1998US5801157 Plasmid contained in oil in water or water in oil emulsion and comprising protein, glycoprotein or peptide
09/01/1998US5801156 Macular degeneration
09/01/1998US5801146 Compound and method for inhibiting angiogenesis
09/01/1998US5801142 Human mts-1 protein
09/01/1998US5801042 Dna and nucleic acids for herpesvirus glycoprotein h, plasmids and genomes
09/01/1998US5801031 Human and rat gamma glutamyl hydrolase genes
09/01/1998US5801029 Cytopathic viruses for therapy and prophylaxis of neoplasia
09/01/1998US5801014 Growth differentiation factor-5
09/01/1998US5801012 Methods and compositions for generating angiostatin
09/01/1998US5800828 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
08/1998
08/28/1998CA2230497A1 Novel lica
08/28/1998CA2230490A1 Novel licc
08/28/1998CA2230478A1 Novel licd2
08/28/1998CA2230473A1 Novel licd1
08/28/1998CA2230467A1 Novel licb
08/27/1998WO1998037240A1 Anti-sense oligonucleotide pharmacological agents
08/27/1998WO1998037217A1 A soluble vaccinia virus protein that binds chemokines
08/27/1998WO1998037209A2 Expression vector for the permanent expression of foreign dna
08/27/1998WO1998037207A1 Antitumor genetic constructs
08/27/1998WO1998037192A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes
08/27/1998WO1998037190A1 Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio
08/27/1998WO1998037188A1 OLIGONUCLEOTIDES SPECIFIC FOR THE marORAB OPERON
08/27/1998WO1998037178A1 Immunomodulatory polypeptides derived from the invariant chain of mhc class ii
08/27/1998WO1998037094A2 Secreted proteins and polynucleotides encoding them
08/27/1998WO1998037091A2 Modified retinoblastoma tumor suppressor proteins
08/27/1998WO1998037089A2 Matrix derived anti-hiv peptides and transdominant proteins
08/27/1998WO1998037085A1 Netrin receptors
08/27/1998WO1998036779A2 System for the in vivo delivery and expression of heterologous genes in the bone marrow
08/27/1998WO1998023260A3 Non-ionic surfactant vesicles as a delivery agent for nucleic acid
08/27/1998WO1998022140A3 Hybrid compositions for intracellular targeting
08/27/1998WO1998017814A3 Gene expression and delivery systems and uses
08/27/1998WO1998013499A3 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
08/27/1998WO1998006437A3 Compositions and methods for polynucleotide delivery
08/27/1998CA2283090A1 Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio
08/27/1998CA2281899A1 Modified retinoblastoma tumor suppressor proteins
08/27/1998CA2281059A1 Secreted proteins and polynucleotides encoding them
08/26/1998EP0860506A1 Human protein kinase hYAKI (HOACF 72)
08/26/1998EP0860502A1 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor
08/26/1998EP0860445A1 New nucleotide sequences for the cell cycle regulated expression of structural genes
08/26/1998EP0860167A1 RNA-and DNA- based active agents in nanoparticles
08/26/1998EP0859860A1 Diagnosis of susceptibility to cancer and treatment thereof
08/26/1998EP0859857A1 Cationic polyacrylates and poly(alkyl)acrylates or the corresponding acrylamides for use in synthetic transfection or blocking systems
08/26/1998EP0859855A1 In vitro construction of sv40 viruses and pseudoviruses
08/26/1998EP0859853A1 Method for transferring genes to the heart using aav vectors
08/26/1998EP0859847A1 Composition and method of imparting resistivity to hiv superinfection to cells
08/26/1998EP0859845A1 Novel cell surface protein compounds
08/26/1998EP0859844A1 Interleuken-3 (il-3) receptor agonists
08/26/1998EP0859837A2 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
08/26/1998EP0859787A1 G-protein coupled receptor hnfds78
08/26/1998EP0859640A1 Method for restoring glucose responsiveness to insulin secretion
08/26/1998EP0859639A1 Methods for treating cancers and restenosis with p21
08/26/1998EP0859638A1 Method for inhibiting cell-mediated killing of target cells
08/26/1998EP0859637A1 Compositions for the treatment and diagnosis of body weight disorders, including obesity
08/26/1998EP0859636A1 Hyaluronic acid as dna carrier for gene therapy and vegf antisense dna to treat abnormal retinal vascularization
08/26/1998EP0859628A1 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
08/26/1998CN1191574A Synthetic mammalian chromosone and methods for construction
08/26/1998CN1191491A 结缔组织生长因子 Connective tissue growth factor
08/26/1998CA2225174A1 Rat cathepsin k polynucleotide & polypeptide sequence
08/25/1998US5798491 Multi-mechanistic chemical cleavage using certain metal complexes
08/25/1998US5798265 Encoding rna complementary to message rna; antisense agents
08/25/1998US5798264 Expression vectors, transformed cells
08/25/1998US5798257 Nucleic acid encoding human MTS-1 protein
08/25/1998US5798113 Grafting a vehicle containing core which contains isolated cells, either suspended in liquid or immobilized within hydrogel matrix, surrounded by a biocompatible jacket which protects isolated cells in core from immunological attack
08/25/1998US5798100 Multi-stage cascade boosting vaccine
08/25/1998US5797870 To deliver a gene therapy agent to epicardial/pericardial tissue
08/25/1998CA2224111A1 Novel compounds
08/24/1998CA2220855A1 Cdna clone hdpb130 that encodes a novel human 7-transmembrane receptor
08/21/1998CA2224085A1 Aroe
08/20/1998WO1998036098A1 Diagnosis and treatment of glaucoma
08/20/1998WO1998036067A2 Secreted proteins and polynucleotides encoding them
08/20/1998WO1998036062A1 Neural cell adhesion molecule splicing variants
08/20/1998WO1998036061A2 Reducing fibrosis and/or scarring by inhibiting interleukin-6 receptor-mediated activity
08/20/1998WO1998036059A2 Prion propagation inhibition by dominant-negative prion protein mutants
08/20/1998WO1998036055A1 Gene therapy for alleviating erectile dysfunction
08/20/1998WO1998035984A2 Compositions and methods for highly efficient transfection
08/20/1998WO1998035979A1 Oligomers which inhibit expression of collagen genes
08/20/1998WO1998035706A2 Enhanced delivery to biological structures
08/20/1998WO1998035695A1 Wound healing
08/20/1998WO1998035693A2 Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
08/20/1998WO1998035689A1 Expression of active human factor ix in mammary tissue of transgenic animals
08/20/1998WO1998035674A1 Compositions for the inhibition of bone resorption
08/20/1998WO1998035562A1 Polynucleotide vaccine formulations
08/20/1998WO1998035554A2 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
08/20/1998WO1998020146A3 Stabilized transient gene expression
1 ... 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 ... 870